logo
Plus   Neg
Share
Email

Alexion Pharma Raises 2018 Guidance; Q1 Profit Beats Estimates - Quick Facts

Alexion Pharmaceuticals, Inc. (ALXN) announced the company now expects 2019 adjusted earnings per share in the range of $9.25 to $9.45, up from previous guidance range of $9.10 to $9.30. For 2019, the company projects total revenues of $4.675 billion to $4.750 billion, revised from prior outlook range of $4.625 billion to $4.700 billion. Analysts polled by Thomson Reuters expect the company to report profit per share of $9.31 on revenue of $4.75 billion, for fiscal year. Analysts' estimates typically exclude special items.

For the first-quarter, non-GAAP EPS was $2.39, compared to $1.68, a year ago. On average, 18 analysts polled by Thomson Reuters expected the company to report profit per share of $2.19 for the quarter.

First-quarter total net product sales were $1.14 billion, compared to $930.4 million, last year. Analysts expected revenue of $1.13 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT